Skip to main content
. 2010 May 27;182(6):784–789. doi: 10.1164/rccm.201002-0211OC

TABLE 3.

MORTALITY AFTER BRONCHIOLITIS OBLITERANS SYNDROME IS UNAFFECTED BY POST–BRONCHIOLITIS OBLITERANS SYNDROME TREATMENTS

Treatment % N HR 95% CI P Value
Nissen fundoplication 11 (10) 1.52 0.63–3.67 0.35
Alemtuzumab 13 (12) 1.37 0.58–3.24 0.47
Antithymocyte globulin 37 (35) 1.25 0.69–2.29 0.46
Azithromycin 58 (55) 1.44 0.78–2.65 0.24

Definition of abbreviations: CI = confidence interval; HR = hazard ratio.